-+ 0.00%
-+ 0.00%
-+ 0.00%

CELLECTAR BIOSCIENCES PROVIDES UPDATE ON CLOVER-2 PHASE 1 CLINICAL TRIAL OF IOPOFOSINE I 131 IN PEDIATRIC PATIENTS WITH RELAPSED/REFRACTORY HIGH-GRADE GLIOMA

Reuters·06/11/2025 12:05:00

Please log in to view news